Position in ELAN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$515,948
-$921,622 QoQ
Shares Held
20,965
-65.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#284
of 520 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ALLSTATE CORP holds $12,621,708 across 13 Drug Manufacturers - Specialty & Generic names. ELAN ranks #8 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
146,154 | $2,320,925 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
46,744 | $2,209,588 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
12,444 | $2,097,311 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
3,453 | $1,870,938 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
23,865 | $827,399 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
5,470 | $606,841 | |
| 7 | ALKS |
Alkermes plc.
|
10,584 | $554,601 | |
| 8 | ELAN |
Elanco Animal Health Inc
This page
|
20,965 | $515,948 |
All Filings in ELAN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $515,948 | 20,965 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,437,570 | 60,074 | Shares | Sole | 2026-05-11 | |
| 2022-09-30 | $426,060 | 34,332 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $1,803,549 | 63,550 | Shares | Sole | 2022-02-15 | |
| 2021-06-30 | $262,187 | 7,558 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $263,135 | 8,935 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $239,226 | 7,800 | Shares | Sole | 2021-02-12 | |
| 2020-03-31 | $230,102 | 10,277 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||